News

Pelthos Therapeutics CEO Engages at Healthcare Conference

Pelthos Therapeutics CEO Engages at Healthcare Conference

Pelthos Therapeutics at the Annual Healthcare Conference

DURHAM, N.C. — Pelthos Therapeutics Inc. (NYSE American: PTHS), a dedicated biopharmaceutical company focused on developing innovative therapies for patients, is poised to highlight its contributions at the upcoming Piper Sandler 37th Annual Healthcare Conference. The event will take place on December 4 at The Lotte New York Palace, and Scott Plesha, the CEO of Pelthos, is set to engage in a fireside chat at 9:30 a.m. Eastern Time.

Fireside Chat Details

This is an exciting opportunity for institutional investors to gain insights directly from Mr. Plesha regarding the company's mission and goals. Investors attending the conference in person are encouraged to arrange one-on-one meetings through their Piper Sandler representatives. This interaction will provide a platform to discuss Pelthos' strategic vision and existing innovations in the biopharmaceutical landscape.

Webcast Opportunity for Remote Attendees

For those who cannot attend the conference live, Pelthos is offering a web streaming option. A live broadcast of the fireside chat will be accessible on Pelthos's News & Events page shortly after the event. This arrangement ensures that even remote investors can be a part of the conversation surrounding the latest advancements in Pelthos' therapeutic developments.

Focus on Patient-Centric Therapeutics

Pelthos Therapeutics is committed to addressing unmet patient needs through its innovative approach to biopharmaceuticals. Key among its product line is ZELSUVMI™ (berdazimer) topical gel, which is designed for the treatment of molluscum contagiosum. Approved by the U.S. Food and Drug Administration recently, ZELSUVMI represents a significant stride in offering effective solutions for conditions that have long been overlooked.

Commitment to Innovation

Pelthos' approach is not just about providing a product; it's about transforming lives through science and innovation. The company’s dedication to creating safe, efficacious treatments exemplifies its commitment to patients who often struggle with treatment options. The introduction of ZELSUVMI demonstrates Pelthos' vision of bridging the gap in therapeutic interventions.

About Pelthos Therapeutics

Pelthos Therapeutics stands out in the biopharmaceutical sector due to its unwavering focus on creating revolutionary therapies aimed at improving patient outcomes. With a roster of promising products and a commitment to clinical excellence, Pelthos is redefining treatment paradigms for various conditions. Their innovative solutions stem from rigorous research and a deep understanding of patient needs.

Contact Information

For inquiries regarding Pelthos Therapeutics, please reach out to the contacts below:

Investors:
Mike Moyer
LifeSci Advisors, LLC
Email: mmoyer@lifesciadvisors.com

Media:
Kellie Walsh
KWM Communications
Email: pelthos@kwmcommunications.com
Phone: (914) 315-6072

Frequently Asked Questions

What is Pelthos Therapeutics focused on?

Pelthos Therapeutics is dedicated to developing innovative therapeutic products aimed at addressing unmet patient needs.

When will the fireside chat take place?

The fireside chat is scheduled for December 4 at 9:30 a.m. Eastern Time during the Piper Sandler Annual Healthcare Conference.

How can investors participate?

Investors attending the conference can schedule one-on-one meetings with Pelthos’ CEO via their Piper Sandler representatives.

What product did Pelthos recently launch?

Pelthos launched ZELSUVMI™, a topical gel approved for the treatment of molluscum contagiosum.

How can I learn more about Pelthos Therapeutics?

For more information, you can visit the company's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 485

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Inter Miami CF: New Era's Champions Collection Launch

Updated Category News Views 246

New Era Launches 2025 MLS Champions Collection In an exciting move for soccer enthusiasts, New Era has announced its 2025 MLS Champions Collection, dedicated to celebrating the remarkable achievements of Inter Miami CF. As the official On-Field Cap partner of Major League Soccer (MLS), New Era has taken this opportunity to honor the victorious spirit of Inter Miami. A...

Continue Reading
Birkenstock's Growth Projections are Set to Surge in 2025

Updated Category News Views 368

Birkenstock's Revenue Outlook for 2025 Birkenstock Holding plc (NYSE: BIRK) recently saw its shares rise significantly as the iconic footwear company reiterated its optimistic outlook for the upcoming fiscal year. The company's executives have announced expectations for a revenue of at least 2.09 billion euros, which translates to approximately $2.25 billion for fiscal...

Continue Reading
Fermi's Board Drama: Neugebauer's Play for Change

Updated Category News Views 55

Two Women, One Baby: The Fermi Saga Boils Over Crack open the newspapers, folks, because Toby Neugebauer’s campaign against Fermi's board reads like high-stakes drama right out of Dallas. He’s practically drawing parallels to King Solomon’s story—two women, one baby. This Corporation ain't no nursery though—it's a high-stakes boardroom battle with Neugebauer...

Continue Reading
Understanding U.S. Housing Shortage Through Neighborhood Analysis

Updated Category News Views 396

New Insights on Housing Supply and Demand Recent data indicates a national shortage of approximately two million housing units, revealing significant gaps in middle-income neighborhoods while wealthier areas may have surpluses. The analysis unveils critical disparities that demand urgent attention and action from policymakers. Neighborhood-Level Analysis of Housing...

Continue Reading
Truist's Commitment of $725 Million for Community Recovery

Updated Category News Views 328

Truist's Major Initiative for Community Support Truist Financial Corporation (NYSE: TFC) has unveiled a transformative plan aimed at driving recovery and enhancing community resilience. The initiative, known as Truist Cares, will dedicate an impressive $725 million over three years to support various critical areas. Focus Areas of the Initiative The resources raised...

Continue Reading